← Leaderboards
Yared Hailemichael
7 Hills Pharma, Llc
$667,133
Attributed
$2,001,399
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–19$2M$1.5M$1M$500K$0
'18
'19
Funding mix
By agency
NIH$2,001,399 · 1
By mechanism
R42$2,001,399 · 1
Top collaborators
- Upendra Marathi2 shared
- Darren G Woodside2 shared
Most similar at 7 Hills Pharma, Llc
Same institution · by research overlap
- Peter Vanderslice$1,627,443
- William Schary$1,136,559
- Siddhartha De$1,468,770
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAnimal ModelAnalogAntibodiesAnti-CancerAntigen PresentationAntitumor ResponseAutoimmune DiseasesBaseBiodistributionBiological AvailabilityBiomarker DevelopmentBiomarker DiscoveryBladderCancer ImmunotherapyCarcinomaCell AdhesionCell Adhesion MoleculesCellsCharacteristicsCheckpoint ReceptorsChemotaxisClinical TrialsClinical Trials Design
Grant awards (2)
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer$1,001,898
R42 · FY2019 · CA
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer$999,501
R42 · FY2018 · CA